Diagnosing a Meningioma
A lesion is likely a meningioma when MRI brain without and with IV contrast demonstrates homogeneous dural-based enhancement, a dural tail (tapering extension along adjacent dura), and a CSF cleft between tumor and brain. 1
Classic Imaging Features
The diagnosis of meningioma relies primarily on characteristic MRI findings that include:
- Homogeneous dural-based enhancement after contrast administration
- Dural tail sign: A tapering extension of enhancement along the adjacent dura mater
- CSF cleft: A visible cerebrospinal fluid space between the tumor and brain parenchyma
- Intratumoral calcifications: Can be present and are best visualized with susceptibility-weighted imaging (SWI) 1
These features on MRI without and with IV contrast provide the diagnostic foundation for identifying meningiomas as extraaxial brain tumors.
Additional Supportive Findings
Beyond the classic triad, meningiomas demonstrate several other characteristic features:
- Reduced diffusion: Often present on diffusion-weighted imaging, though this finding is not specific to meningiomas 1
- Vasogenic edema: Can occur in subjacent brain parenchyma, particularly with specific histologic subtypes (angiomatous and secretory meningiomas), though this does not reliably predict WHO grade 1
- High vascularity: Meningiomas are highly vascular tumors, making perfusion imaging with arterial spin labeling (ASL) MRI useful for noninvasive grading 1
Red Flags for Meningioma Mimics
Critical caveat: Not all dural-based lesions are meningiomas. Be alert for atypical features that suggest alternative diagnoses:
- Marked T2-hypointensity or hyperintensity (meningiomas typically show intermediate signal)
- Absence of a dural tail
- Dural displacement sign (suggests the lesion is pushing rather than arising from the dura) 1
These findings should prompt consideration of meningioma mimics including:
- Cavernous malformations (can appear identical to meningiomas, even intraoperatively) 2
- Multiple myeloma (particularly with destructive calvarial lesions) 3
- Metastatic disease
- Hemangiopericytoma
Advanced Imaging for Specific Scenarios
For cases requiring additional characterization:
- SSTR PET imaging (DOTATATE, DOTATOC, or DOTANOC): Provides extraordinarily high lesion-to-background contrast with detection sensitivity superior to contrast-enhanced MRI alone, particularly valuable for skull base lesions where morphologic borders are difficult to assess 4
- DCE MRI characteristics: Correlate with DOTATATE avidity in higher-grade meningiomas 1
- Functional MRI: May be helpful for surgical planning when tumors involve eloquent brain regions, such as lateral ventricular meningiomas where it can improve visual field preservation and reduce postoperative aphasia 1
Atypical Presentations Requiring Heightened Awareness
Meningiomas can present in diagnostically challenging ways:
- Cystic meningiomas: May mimic intraparenchymal cystic tumors (hemangioblastoma, ganglioglioma, pilocytic astrocytoma) with cystic lesions and enhancing mural nodules 5, 6
- Intraosseous (ectopic) meningiomas: Account for <1% of all meningiomas, can show mixed osteolytic-sclerotic patterns mimicking primary bone tumors or metastases 7
- Optic nerve sheath meningiomas: Consistently bind SSTR ligands, making SSTR PET particularly useful for this entity 4
Diagnostic Algorithm
- Obtain MRI brain without and with IV contrast as the primary diagnostic modality 1
- Assess for classic triad: dural-based enhancement, dural tail, CSF cleft
- Evaluate for red flags: marked T2 signal abnormality, absent dural tail, dural displacement
- Consider SSTR PET for ambiguous cases, skull base locations, or when differentiating from posttherapeutic scar tissue 4
- Add perfusion imaging if grading information would alter management 1
The combination of typical imaging features on contrast-enhanced MRI provides high diagnostic confidence, but maintaining awareness of atypical presentations and mimics prevents diagnostic errors that could impact surgical planning and patient counseling.